$ Value
$0
Shares
94,250
Price
$0
Filed
Mar 31
Insider
Name
Okazaki Jason A
Title
CEO and President
CIK
0001807214
Roles
Transaction Details
Transaction Date
2026-03-29
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
111,916
Footnotes
Grant of restricted stock units ("RSUs"). The RSUs vest in four approximately equal installments, assuming continuous service on each vesting date, as follows: March 29, 2027; March 29, 2028; March 29, 2029; and March 29, 2030. | RSUs represent 65% of the reporting person's annual equity grant. The remaining 35% of the RSUs granted are contingent upon stockholder approval of an amendment to the Issuer's Amended and Restated 2018 Stock Incentive Plan (the "Plan") that increases the number of shares of common stock authorized for issuance under the Plan. | Includes 2,909 shares acquired under the Assembly Biosciences, Inc. Second Amended and Restated 2018 Employee Stock Purchase Plan on May 14, 2025.
Filing Info
Okazaki Jason A's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-29 | ASMB | A | $0 |
Other Insiders at ASMB (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Delaney William E IV
Chief Scientific Officer
|
— | — | 2026-03-29 |
|
Bjorkquist Jeanette M
PFO and PAO
|
— | $9K | 2026-03-30 |
|
White Nicole S
Chief Manufacturing Officer
|
— | $5K | 2026-03-30 |
|
Gaggar Anuj
Chief Medical Officer
|
— | — | 2026-03-29 |